Dapsone 6% / Niacinamide 2% / Tretinoin 0.025%
Product Images NDC 72934-1062

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone 6% / Niacinamide 2% / Tretinoin 0.025% (NDC 72934-1062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Wr (2 End)

Wr (2 End)
This image shows the directions for use label panel on a pharmaceutical container. It instructs to use as directed by a physician, apply topically, wash hands after use, and store at controlled room temperature (20-25°C). It includes contact information for Sincerus Florida, LLC, including phone numbers and a website for reporting adverse reactions.*
FDA Label Image

Dgv (1062 Middle)

Dgv (1062  Middle)
Label of DAPSONE 6% / NIACINAMIDE 2% / TRETINOIN 0.025% gel showing active ingredients listed with their strengths: Dapsone 6%, Niacinamide 2%, Tretinoin 0.025%. Also lists inactive ingredients including Butylated Hydroxytoluene NF (BHT), Propylene Glycol USP, and Suspensisse Gel. The label indicates the product is Rx only with a lot number and manufacture/use dates.*
FDA Label Image

Zsfd (1062 2 Front)

Zsfd (1062 2 Front)
Packaging label of DAPSONE 6% / NIACINAMIDE 2% / TRETINOIN 0.025% gel in a 30gm container. The label shows the product's NDC number 72934-1062-2 and indicates it is a compounded drug made in the USA. The labeler is Sincerus Florida, LLC, with their logo prominently displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.